PCSK9 and type 2 diabetes mellitus: This inverse correlation is not observed in patients without T2DM or in the subgroup of patients not on statins, suggesting that in subjects with diabetes and in particular in statin-treated subjects, enhanced circulating PCSK9 may impair early EPC number, reflecting cardiovascular homeostasis and regenerative capacity.